Good Health Can’t Wait.

Good Health Can’t Wait.
Dr. Reddy’s Laboratories Limited
NOTES TO FINANCIAL STATEMENTS
(All amounts in Indian Rupees millions, except share data and where otherwise stated)
2.8: NON CURRENT INVESTMENTS (CONTINUED)
PARTICULARS
AS AT
31 MARCH 2015
AS AT
31 MARCH 2014
Unquoted trade investments (continued)
In other companies
Equity shares (fully paid-up)
Ordinary shares of Biomed Russia Limited, Russia (b) 66 66
200,000 (previous year: 200,000) ordinary shares of ` 10/- each of Altek Engineering Limited,
India
2 2
8,859 (previous year: 8,859) equity shares of ` 100/- each of Jeedimetla Effluent Treatment
Limited, India
1 1
24,000 (previous year: 24,000) equity shares of ` 100/- each of Progressive Effluent Treatment
Limited, India
2 2
20,250 (previous year: 20,250) equity shares of ` 10/- each of Shivalik Solid Waste Management
Limited, India (c)
- -
71 71
Less: Provision for decline, other than temporary, in the value of non current investments (70) (70)
Total unquoted trade investments in equity shares of other companies, net (C) 1 1
Total unquoted non current investments ( II ) (A+B+C) 17,598 17,398
Total (I + II) 17,601 17,401
Aggregate amount of quoted investments 3 3
Aggregate amount of unquoted investments 18,868 18,668
Aggregate provision for diminution in value of investments 1,270 1,270
Market value of quoted investments 32 23
(a) In respect of shares of State Bank of India, the share certificates were misplaced during transfer/lost in transit. The Company has initiated necessary
legal action at the appropriate courts.
(b) Shares held in Kunshan Rotam Reddy Pharmaceutical Co. Limited, China and Biomed Russia Limited, Russia are not denominated in number of shares
as per the laws of the respective countries.
(c) Rounded off in millions in the note above.
2.9: LONG TERM LOANS AND ADVANCES
PARTICULARS
AS AT
31 MARCH 2015
AS AT
31 MARCH 2014
Unsecured
Considered good
Loans and advances to wholly owned subsidiaries (a) 2,283 3,990
Advance income tax (net of provisions ` 26,557; previous year: ` 22,146) 1,576 903
MAT credit entitlement 644 -
Capital advances for purchase of fixed assets 610 67
Security deposits 418 391
Other advances 7 7
Considered doubtful
Loans and advances to wholly owned subsidiaries (a) 1,059 866
Others 8 8
6,605 6,232
Less: Provision for doubtful loans and advances (Refer Note 2.36) (1,067) (874)
5,538 5,358
130